CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 424B5 Offering Prospectus
- 8-K Event Bylaws or fiscal year change
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Grant or award CEO acquired 15,718 shares (grant or award)
- 4 Grant or award CFO and EVP acquired 7,506 shares (grant or award)
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 36 of 77 · 1,525 filings